Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Chemkart India Ltd (544442)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544442 NSE: Trading | Small Cap | Chemkart India Share Price
₹268.60 12.75 (4.98%)
As on 02-Nov'26 16:59
Chemkart India Ltd (544442)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544442 NSE: Trading | Small Cap | Chemkart India Share Price
₹268.60 12.75 (4.98%)
As on 02-Nov'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹325 Cr.
Current Price
₹268.6
52-Week Low / High
₹87 / 269
TTM EPS
₹16.3
TTM Sales
₹215 Cr.
Book Value per Share
₹107.2
P/E Ratio
16.53
Higher than its 5-year historical median
Industry PE
42
Price to Book (P/B)
2.50
Price to Sales (P/S)
1.51
Higher than its 5-year historical median
EV/EBITDA
10.10
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
21.48%
Outperforms industry median
Return on Capital Employed (ROCE)
27.65%
Outperforms industry median
Return on Assets (ROA)
16.14%
Outperforms industry median
Operating Profit Margin
13.1%
Outperforms industry median
Net Profit Margin
9.15%
Outperforms industry median
Gross Profit Margin
12.8%
Outperforms industry median
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
4.58%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-14.27%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-19.86%
Asset Quality
Promoter Holding
74.88%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹118 Cr.
Equity
₹12.1 Cr.
Face Value
₹10
All Time Low / High
₹87.00 / 268.00
Check Before You Invest
Quality
Not GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Weak
Is Chemkart India Ltd a good quality company?
Chemkart India Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Chemkart India Ltd performance compare with that of its Peers?
Revenue growth of Chemkart India Ltd vs industry peers?
Chemkart India Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0.00%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Chemkart India Ltd?
Promoters hold 74.88% of the Chemkart India Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Chemkart India Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of 20.45% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Chemkart India Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|
| ROCE % ⓘ | 83.2% | 66.8% | 62% | 61.9% | 28.5% | - |
| Value Creation Index ⓘ | 4.9 | 3.8 | 3.4 | 3.4 | 1.0 | - |
Growth Parameters ⓘ |
||||||
| Sales ⓘ | 87 | 131 | 132 | 203 | 213 | 213 |
| Sales YoY Gr. | - | 51.1% | 0.5% | 54% | 4.6% | - |
| Adj EPS ⓘ | 5.5 | 8.2 | 14.1 | 24.5 | 16.9 | 17.2 |
| YoY Gr. | - | 49.9% | 72.5% | 73.9% | -30.9% | - |
| BVPS (₹) ⓘ | 7.2 | 15.6 | 30.3 | 56.3 | 108.3 | 108.3 |
| Adj Net Profit ⓘ | 5.2 | 7.8 | 13.4 | 23.3 | 20.5 | 21 |
| Cash Flow from Ops. ⓘ | -0 | 4.6 | 1.3 | -0.3 | -3.5 | - |
| Debt/CF from Ops. ⓘ | -86.1 | 2.4 | 9.8 | -66.6 | -1.4 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | 17.4% | 4.6% | ||||
| Adj EPS ⓘ | NA | NA | 27.5% | -30.9% | ||||
| BVPSⓘ | NA | NA | 90.8% | 92.3% | ||||
| Share Price | - | - | - | 23.2% | ||||
Key Financial Parameters ⓘ
| Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 75.6 | 71.6 | 61.4 | 56.6 | 22.2 | 15.9 |
| Op. Profit Mgn % ⓘ | 8.1 | 8.7 | 15.4 | 16.2 | 13.6 | NAN |
| Net Profit Mgn % ⓘ | 6 | 5.9 | 10.1 | 11.5 | 9.6 | 9.8 |
| Debt to Equity ⓘ | 0.3 | 0.7 | 0.4 | 0.3 | 0 | - |
| Working Cap Days ⓘ | 0 | 83 | 115 | 114 | 162 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 36 | 62 | 76 | 104 | 0 |
Valuation of Chemkart India - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|
| Sales | 87 | 131 | 132 | 203 | 215 |
| Operating Expenses ⓘ + | 80 | 120 | 111 | 170 | 187 |
| Operating Profit ⓘ | 7 | 11 | 21 | 33 | 28 |
| Operating Profit Margin (%) | 8.1% | 8.4% | 15.8% | 16.2% | 13.1% |
| Other Income ⓘ + | 0 | 0 | 1 | 2 | 1 |
| Interest ⓘ | 0 | 1 | 1 | 2 | 1 |
| Depreciation ⓘ | 0 | 0 | 0 | 1 | 0 |
| Profit Before Tax ⓘ | 7 | 11 | 20 | 32 | 27 |
| Tax ⓘ | 2 | 3 | 5 | 8 | 7 |
| Profit After Tax | 5 | 8 | 15 | 25 | 20 |
| PAT Margin (%) | 6.3% | 5.8% | 11.0% | 12.1% | 9.2% |
| Adjusted EPS (₹) | 5.8 | 8.1 | 15.3 | 25.8 | 16.3 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 7 | 14 | 29 | 53 | 130 | ||||||
| Debt + | 6 | 11 | 12 | 17 | 5 | ||||||
| Minority Interest | 0 | 0 | 0 | -0 | 0 | ||||||
| Trade Payables | 8 | 11 | 10 | 12 | 18 | ||||||
| Others Liabilities ⓘ | 4 | 1 | 3 | 5 | 4 | ||||||
| Total Liabilities ⓘ | 25 | 37 | 54 | 86 | 157 | ||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 1 | 6 | 5 | 9 | 8 | ||||||
| CWIP ⓘ | 0 | 0 | 0 | 0 | 5 | ||||||
| Investments ⓘ | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventories | 2 | 8 | 8 | 22 | 35 | ||||||
| Trade Receivables | 19 | 22 | 32 | 46 | 50 | ||||||
| Cash Equivalents | 0 | 0 | 0 | 3 | 39 | ||||||
| Others Assets ⓘ | 3 | 2 | 9 | 6 | 21 | ||||||
| Total Assets ⓘ | 25 | 37 | 54 | 86 | 157 | ||||||
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | -6 | 0 | -0 | 4 | -3 |
| Cash Flow From Investing Activity ⓘ + | -1 | -5 | -0 | -4 | -5 |
| Cash Flow From Financing Activity ⓘ + | 7 | 5 | 0 | 3 | 43 |
| Net Cash Flow ⓘ | -0 | 0 | -0 | 3 | 36 |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 80.15 | 71.82 | 66.73 | 59.58 | 21.48 | |||||
| ROCE (%) | 59.75 | 57.94 | 63.21 | 61.4 | 27.65 | |||||
| Asset Turnover Ratio | 3.54 | 4.24 | 2.9 | 2.9 | 1.76 | |||||
| PAT to CFO Conversion(x) | -1.2 | 0 | -0 | 0.16 | -0.15 | |||||
| Working Capital Days | ||||||||||
| Receivable Days | 80.50 | 57.70 | 74.60 | 69.80 | 81.60 | |||||
| Inventory Days | 8 | 13.40 | 21.50 | 27.20 | 48.60 | |||||
| Payable Days | 40.70 | 30.40 | 34.50 | 24.20 | 31.10 | |||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Annual reports
No annual reports available.
Concalls
No concalls available.
Chemkart India Ltd FAQs
The current trading price of Chemkart India on 02-Nov-2026 16:59 is ₹268.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Nov-2026 the market cap of Chemkart India stood at ₹325.0 Cr
The latest P/E ratio of Chemkart India as of 01-Nov-2026 is 15.65.
The latest P/B ratio of Chemkart India as of 01-Nov-2026 is 2.48.
The 52-week high of Chemkart India is ₹268.6 and the 52-week low is ₹87.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chemkart India is ₹213 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Chemkart India Ltd is a below average quality company.
The key valuation ratios of Chemkart India Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Chemkart India Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Chemkart India Ltd
Chemkart India Limited was incorporated on March 06, 2020 as ‘Chemkart India Private Limited’, a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated March 06, 2020 issued by Deputy Registrar of Companies. Further, the company was converted into a public limited company pursuant to a resolution passed by the Board of Directors in their meeting held on August 16, 2024 and by its Shareholders at an Extra-Ordinary General Meeting held on August 16, 2024 at shorter notice and consequently the name of the company was changed to ‘Chemkart India Limited’ and a fresh certificate of incorporation dated October 04, 2024 was issued by Assistant Registrar of Companies/Deputy Registrar of Companies/ Registrar of Companies, Central Processing Centre.
The company is a one stop destination for various nutritional, Health and sports supplement products, which are largely biased towards the food products providing health benefits in addition to their nutritional values, reflecting its ability in catering to nutritional as well as health needs of the end customers. The company is based in Mumbai, offering diverse range of captivated nutritional supplements and components. It offers products across mainly seven product categories, i.e. Amino Acids, Health Supplement, Herbal Extract, Nucleotide, Protein, Sports Nutrition, and Vitamin.
It targets the Business to Business (B-to-B) platform which uses its products into manufacturing of finished supplements which includes sports supplements, health supplements, vitamins, protein products etc. Its product assortment and customer-centric approach aims to fulfil the daily and aspirational requirements of the end customers with a focus on variety, affordability, quality and convenience. Since the commencement of its operations, it has developed good standing relationships with its customers. It also engages actively with its suppliers to improve its supply chain processes.
Business area of the company
The company is mainly engaged in the business of processing and trading of nutritional and health supplements. The company is registered under FSSAI (Food Safety and Standards Authority of India)
Products of the company
- Amino acid
- Health supplement
- Herbal extract
- Nucleotide
- Protein
- Sports nutrition
- Vitamin
History and milestones
- 2020: Incorporation of the company as a private limited company under the name ‘Chemkart India Private Limited’
- 2020: ISO 9001:2015 Quality Management System certified for the following activities Importers, Manufacturers and distributors of Health Supplements, Pharma Bulk Drugs, Food and Feed Ingredients.
- 2021: Received FSSAI License.
- 2024: Certificate of registration re-issued to certify that the quality management systems of the company have been audited and have found to be compliant with standards prescribed under ISO 9001:2015 Received FSSAI License.
- 2024: Certificate of Compliance issued and assessed by GACB that the Plant situated at Office No. 403/404, 4th Floor, K.L. Accolade, 6th Road, TPS III, Santacruz (East), Mumbai, Maharashtra, India, has been audited and assessed and found to comply with the requirements of the HALAL Assurance System Guidelines.
- 2024: Certificate of Compliance issued that confirms that the products manufactured by the company are KOSHER.
- 2024: Certificate of registration issued to certify that audit has been conducted by ICV and found to be in compliance with the quality management systems with standards prescribed under ISO 9001:2015.
- 2024: Converted to Public Limited Company and Name changed to Chemkart India Limited.
- 2024: The company entered into Share Purchase Agreement to acquire majority stake of Easy Raw Materials.
- Private Limited and Vinstar Biotech Private Limited.
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now